Trials / Conditions / Brain Metastases From Non-small Cell Lung Cancer (NSCLC)

Brain Metastases From Non-small Cell Lung Cancer (NSCLC)

7 registered clinical trials studyying Brain Metastases From Non-small Cell Lung Cancer (NSCLC) — 5 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	Stereotactic Radiation for Growing/Changing Brain Metastases With Same-Day Radiation Planning and Treatment Wi NCT07132190	Ayal A. Aizer, MD	Phase 2
Recruiting	Prophylactic Anti-Seizure Medication vs No Anti-Seizure Medication for Patients With Primary Motor Cortex Brai NCT07130786	Ayal A. Aizer, MD	Phase 2
Not Yet Recruiting	Avoiding Radiation Therapy Due to Intracranial Response to Chemotherapy, Targeted Therapy and/or Immuno-ONcolo NCT06974370	University of Vermont Medical Center	Phase 2
Not Yet Recruiting	Risk and Prognosis of Brain Metastasis in Non-Small Cell Lung Cancer NCT07034365	Fudan University	—
Recruiting	Novel Ga68-PSMA PET/CT-tracer to Differentiate Between Radiation Necrosis and Tumor Progression in Brain Metas NCT07511933	The Netherlands Cancer Institute	N/A
Active Not Recruiting	Osimertinib Combined With Intracranial SRT for EGFR-Mutant NSCLC With Symptomatic Brain Metastases NCT07491211	Fudan University	—
Completed	Pivotal, Open-label, Randomized Study of Radiosurgery With or Without Tumor Treating Fields (TTFields) for 1-1 NCT02831959	NovoCure GmbH	Phase 3